Why staying connected matters for today’s qualified persons

Published: 6-Oct-2026 Featured companies: NSF
Regulatory

Helen explains how the NSF QP Alumni community helps Qualified Persons stay current through regulatory updates, peer discussions and shared experience, offering practical insight into evolving industry challenges

Promoted Content Why staying connected matters for today’s qualified persons

How do Qualified Persons stay up to date with evolving industry practices and regulatory expectations?

In this short testimonial, Helen explains the value of staying connected with fellow Qualified Persons and regulators through the NSF QP Alumni community.

Alongside formal presentations and regulatory updates, Helen highlights the importance of the informal discussions that take place throughout the event, helping QPs exchange ideas, learn from one another and gain practical insights into current industry challenges.

Featured companies

Founded in 1944, NSF’s mission is to protect and improve global human health. NSF, Pharmaceutical Services provides a comprehensive range of independent, third-party...
See more

You may also like

Manufacturing
FDA inspection readiness: Preparing for surveillance and pre-approval inspections

FDA inspection readiness: Preparing for surveillance and pre-approval inspections

Read more
Preparing pharma and biotech teams for continuous FDA inspection readiness, mock inspections and proactive regulatory risk management

Trending Articles

  1. From Indonesia to the world: support Beta Pharmacon’s manufacturing excellence with GEA granulation technology By integrating GEA granulation technology into its new facility, Beta Pharmacon has enhanced process control, reinforced its commitment to regulatory compliance, and secured GMP and USP qualifications to supply essential micronutrient supplements
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    GLP-1 patent applications surge 146% in five years as semaglutide cliff drives evergreening and biosimilar race Pinsent Masons data shows 936 filings in the year to March 2026 — spanning oral formulations, method-of-use patents for conditions including cancer and Parkinson's and generic alternatives ahead of semaglutide's European expiry in 2031
  3. Neuraxpharm and Minoryx secure EU approval for cALD drug Nezglyal The European Commission has granted marketing authorisation for Nezglyal (leriglitazone), the first pharmacological treatment approved in the EU for cerebral adrenoleukodystrophy (cALD)
  4. FDA Form 483 explained: responding to findings and managing regulatory risk Explore what a Form FDA 483 means, how to respond within 15 business days, assess patient risk, address observations and understand how FDA evaluates responses and inspection outcomes
  5. Leica Biosystems brings Tempus pathology products to Aperio AI Store Expanding the Aperio AI Store gives researchers more ways to study cancer through AI-enabled tools within a connected digital pathology ecosystem

Relevant companies

See more

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Manufacturing
FDA inspection readiness: Preparing for surveillance and pre-approval inspections

FDA inspection readiness: Preparing for surveillance and pre-approval inspections

Preparing pharma and biotech teams for continuous FDA inspection readiness, mock inspections and proactive regulatory risk management
Manufacturing
FDA Form 483 explained: responding to findings and managing regulatory risk

FDA Form 483 explained: responding to findings and managing regulatory risk

Explore what a Form FDA 483 means, how to respond within 15 business days, assess patient risk, address observations and understand how FDA evaluates responses and inspection outcomes
Training & Education
Europe’s pharma quality benchmark: The insights every leader must know

Europe’s pharma quality benchmark: The insights every leader must know

Explore NSF’s 2025 European Pharma & Biotech Benchmarking Study, revealing how 100 quality and regulatory leaders assess quality systems, data integrity, supply chains, AI and regulatory readiness
Training & Education
Corporate in-house training for health sciences

Corporate in-house training for health sciences

Contact NSF to discuss your company’s training needs
Regulatory
Pharma and biotech industry audit services for GMP, GxP and supplier compliance

Pharma and biotech industry audit services for GMP, GxP and supplier compliance

NSF experts perform audits and mock inspections across the product lifecycle. Read the article to find out more its audit services
Sustainability
Why QP Alumni connections continue to matter long after QP Training

Why QP Alumni connections continue to matter long after QP Training

Matt explains how the NSF QP Alumni community provides lasting professional connections, peer support and continuing development, helping Qualified Persons share challenges and learn from experience
Sustainability
How the right professional community can build confidence as a QP

How the right professional community can build confidence as a QP

Discover how the NSF QP Alumni community provides broader industry perspective, trusted connections and fresh insight
Subscribe now